AwesomeCapital
Tuesday, December 4, 2018
BioCryst Pharma (BCRX) PT Raised to $16 at RBC
Sees Continued Upside: RBC Capital analyst Brian Abraham raised the price target on BioCryst Pharma (NASDAQ: BCRX) to $16.00
https://www.streetinsider.com/Analyst+Comments/BioCryst+Pharma+%28BCRX%29+PT+Raised+to+%2416+at+RBC+Capital%3B+Sees+Continued+Upside/14887718.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.